1. Home
  2. ETNB vs TRS Comparison

ETNB vs TRS Comparison

Compare ETNB & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • TRS
  • Stock Information
  • Founded
  • ETNB 2018
  • TRS 1986
  • Country
  • ETNB United States
  • TRS United States
  • Employees
  • ETNB N/A
  • TRS N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • TRS Industrial Specialties
  • Sector
  • ETNB Health Care
  • TRS Industrials
  • Exchange
  • ETNB Nasdaq
  • TRS Nasdaq
  • Market Cap
  • ETNB 864.2M
  • TRS 969.0M
  • IPO Year
  • ETNB 2019
  • TRS 2007
  • Fundamental
  • Price
  • ETNB $6.31
  • TRS $24.24
  • Analyst Decision
  • ETNB Buy
  • TRS Strong Buy
  • Analyst Count
  • ETNB 7
  • TRS 1
  • Target Price
  • ETNB $30.33
  • TRS $40.00
  • AVG Volume (30 Days)
  • ETNB 1.3M
  • TRS 214.9K
  • Earning Date
  • ETNB 02-27-2025
  • TRS 02-27-2025
  • Dividend Yield
  • ETNB N/A
  • TRS 0.66%
  • EPS Growth
  • ETNB N/A
  • TRS N/A
  • EPS
  • ETNB N/A
  • TRS 0.64
  • Revenue
  • ETNB N/A
  • TRS $906,520,000.00
  • Revenue This Year
  • ETNB N/A
  • TRS $4.36
  • Revenue Next Year
  • ETNB N/A
  • TRS $4.92
  • P/E Ratio
  • ETNB N/A
  • TRS $37.86
  • Revenue Growth
  • ETNB N/A
  • TRS 2.17
  • 52 Week Low
  • ETNB $5.99
  • TRS $22.24
  • 52 Week High
  • ETNB $16.63
  • TRS $28.51
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 31.27
  • TRS 49.07
  • Support Level
  • ETNB $5.99
  • TRS $22.59
  • Resistance Level
  • ETNB $6.65
  • TRS $24.57
  • Average True Range (ATR)
  • ETNB 0.40
  • TRS 0.71
  • MACD
  • ETNB -0.14
  • TRS 0.11
  • Stochastic Oscillator
  • ETNB 15.70
  • TRS 74.07

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About TRS TriMas Corporation

TriMas Corp is a United States-based company that designs, manufactures, and distributes engineered and applied products. The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

Share on Social Networks: